ONO 7268MX2Alternative Names: ONO7268MX2; Peptide-based cancer vaccine - OncoTherapy Science/Ono Pharmaceutical
Latest Information Update: 28 Mar 2016
At a glance
- Originator OncoTherapy Science
- Developer Immunovaccine; OncoTherapy Science; Ono Pharmaceutical
- Class Cancer vaccines; Peptide vaccines; Peptides
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Hepatocellular carcinoma
- Research Cancer